I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 7 studies | 21% ± 6% | |
| endothelial cell | 5 studies | 26% ± 10% | |
| smooth muscle cell | 5 studies | 17% ± 2% | |
| epithelial cell | 5 studies | 31% ± 17% | |
| ciliated cell | 5 studies | 30% ± 8% | |
| type I pneumocyte | 5 studies | 19% ± 3% | |
| natural killer cell | 4 studies | 17% ± 1% | |
| myofibroblast cell | 4 studies | 19% ± 2% | |
| pancreatic A cell | 3 studies | 19% ± 1% | |
| type B pancreatic cell | 3 studies | 32% ± 4% | |
| B cell | 3 studies | 19% ± 4% | |
| CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| adipocyte | 3 studies | 20% ± 7% | |
| connective tissue cell | 3 studies | 22% ± 5% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 3% |
